Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
Mood disorders are associated with an increased risk of aging-related diseases, which greatly contribute to the excess morbidity and mortality observed in affected individuals. Clinical and molecular findings also suggest that mood disorders might be characterized by a permanent state of low-grade inflammation. At the cellular level, aging translates into telomeres shortening. Intriguingly, inflammation and telomere shortening show a bidirectional association: a pro-inflammatory state seems to contribute to aging and telomere dysfunction, and telomere attrition is able to induce low-grade inflammation. Several independent studies have reported shorter telomere length and increased levels of circulating inflammatory cytokines in mood disorders, suggesting a complex interplay between altered inflammatory⁻immune responses and telomere dynamics in the etiopathogenesis of these disorders. In this review, we critically discuss studies investigating the role of telomere attrition and inflammation in the pathogenesis and course of mood disorders, and in pharmacological treatments with psychotropic medications.
['Squassina|Alessio|A|', 'Pisanu|Claudia|C|', 'Vanni|Roberta|R|0000-0003-1367-5958']
D019588:Aging, Premature D000818:Animals D006801:Humans D007249:Inflammation D051379:Mice D019964:Mood Disorders D011619:Psychotropic Drugs D051381:Rats D059506:Telomere Shortening
mood disorders aging inflammation telomere shortening antidepressants bipolar disorder lithium major depression mood stabilizers